Tissue factor at the crossroads of coagulation and radiation response in glioblastoma

Journal of Thrombosis and Haemostasis - Tập 22 - Trang 3-6 - 2024
Nigel Mackman1,2, Nadim Tawil3,4, Janusz Rak3,4
1Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill, North Carolina, USA
2University of North Carolina at Chapel Hill Blood Research Center, The University of North Carolina at Chapel Hill, North Carolina, USA
3Department of Experimental Medicine, McGill University, Montreal, Quebec Canada
4Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada

Tài liệu tham khảo

Jeon, 2023, Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling, Cancer Cell, 41, 1480, 10.1016/j.ccell.2023.06.007 Grover, 2018, Tissue factor: an essential mediator of hemostasis and trigger of thrombosis, Arterioscler Thromb Vasc Biol, 38, 709, 10.1161/ATVBAHA.117.309846 Tawil, 2021, Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles, Blood Adv, 5, 1682, 10.1182/bloodadvances.2020002998 Wang, 2012, Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer, Blood, 119, 5543, 10.1182/blood-2012-01-402156 Hisada, 2017, Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size, J Thromb Haemost, 15, 2208, 10.1111/jth.13809 Verheij, 1995, The effect of ionizing radiation on endothelial tissue factor activity and its cellular localization, Thromb Haemost, 73, 894, 10.1055/s-0038-1653889 Szotowski, 2007, Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells, Cardiovasc Res, 73, 806, 10.1016/j.cardiores.2006.12.018 Eisenreich, 2008, Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel, Int Immunopharmacol, 8, 307, 10.1016/j.intimp.2007.06.005 Baskar, 2012, Cancer and radiation therapy: current advances and future directions, Int J Med Sci, 9, 193, 10.7150/ijms.3635 Zelaya, 2018, Tissue factor at the crossroad of coagulation and cell signaling, J Thromb Haemost, 16, 1941, 10.1111/jth.14246 Green, 2010, Role of thrombin as a tumor growth factor, Cell Cycle, 9, 656, 10.4161/cc.9.4.10729 Steinbrecher, 2010, Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin αMβ2 engagement of fibrinogen, Cancer Res, 70, 2634, 10.1158/0008-5472.CAN-09-3465 Sharma, 2021, Fibrinogen activates focal adhesion kinase (FAK) promoting colorectal adenocarcinoma growth, J Thromb Haemost, 19, 2480, 10.1111/jth.15440 Morrissey, 1988, Monoclonal antibody analysis of purified and cell-associated tissue factor, Thromb Res, 52, 247, 10.1016/0049-3848(88)90084-9 Hu, 1999, Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model, Proc Natl Acad Sci U S A, 96, 8161, 10.1073/pnas.96.14.8161 Gogia, 2023, Antibody–drug conjugates: a review of approved drugs and their clinical level of evidence, Cancers, 15, 3886, 10.3390/cancers15153886 Breij, 2014, An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors, Cancer Res, 74, 1214, 10.1158/0008-5472.CAN-13-2440 Koga, 2015, Antitumor effect of antitissue factor antibody-MMAE conjugate in human pancreatic tumor xenografts, Int J Cancer, 137, 1457, 10.1002/ijc.29492 Zhang, 2017, Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma, Oncotarget, 8, 59086, 10.18632/oncotarget.19175 Theunissen, 2018, Treating tissue factor-positive cancers with antibody-drug conjugates that do not affect blood clotting, Mol Cancer Ther, 17, 2412, 10.1158/1535-7163.MCT-18-0471 Coleman, 2021, Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study, Lancet Oncol, 22, 609, 10.1016/S1470-2045(21)00056-5 Abounader, 2021, The blood-brain barrier limits the therapeutic efficacy of antibody-drug conjugates in glioblastoma, Neuro Oncol, 23, 1993, 10.1093/neuonc/noab223 Greene, 2010, Animal Models Subcommittee of the Scientific And Standardization Committee of the ISTH AMSotSASCOT. Towards a standardization of the murine tail bleeding model, J Thromb Haemost, 8, 2820, 10.1111/j.1538-7836.2010.04084.x Wang, 2009, Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice, J Thromb Haemost, 7, 1092, 10.1111/j.1538-7836.2009.03448.x Wen, 2020, Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions, Neuro Oncol, 22, 1073, 10.1093/neuonc/noaa106 Riedl, 2017, Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism, Blood, 129, 1831, 10.1182/blood-2016-06-720714